Results 1 to 10 of about 204,040 (168)

Current Guidelines for Management of Medullary Thyroid Carcinoma [PDF]

open access: yesEndocrinology and Metabolism, 2021
Medullary thyroid carcinoma (MTC) is a rare neuroendocrine tumor originating from the parafollicular cells. The diagnostic and therapeutic strategies for the condition are different from those used for well-differentiated thyroid cancer.
Mijin Kim, Bo Hyun Kim
doaj   +1 more source

Trends in the Diagnosis and Treatment of Patients with Medullary Thyroid Carcinoma in Korea [PDF]

open access: yesEndocrinology and Metabolism, 2020
Background Thyroid cancer is becoming increasingly common worldwide, but little is known about the epidemiology of medullary thyroid carcinoma (MTC). This study investigated the current status of the incidence and treatment of MTC using Korean National ...
Hwa Young Ahn   +5 more
doaj   +1 more source

Initial Experiences of Selective RET Inhibitor Selpercatinib in Adults with Metastatic Differentiated Thyroid Carcinoma and Medullary Thyroid Carcinoma: Real-World Case Series in Korea

open access: yesCurrent Oncology, 2023
Recently, selpercatinib, a highly selective inhibitor of RET receptor tyrosine kinase, has been used for RET-altered thyroid cancer. We present four cases of patients with advanced thyroid cancer who were treated with selpercatinib. The first patient was
Han-Sang Baek   +5 more
doaj   +1 more source

Navigating the Current Landscape of Non-Clear Cell Renal Cell Carcinoma: A Review of the Literature

open access: yesCurrent Oncology, 2023
Non-clear cell renal cell carcinoma (nccRCC) is an entity comprised of a heterogeneous constellation of RCC subtypes. Genomic profiling has broadened our understanding of molecular pathogenic mechanisms unique to individual nccRCC subtypes.
Alexius John   +2 more
doaj   +1 more source

Renal medullary necrosis [PDF]

open access: yesThe American Journal of Medicine, 1952
Abstract Patients with diabetes and/or obstruction of the urinary tract and infection are predisposed to inflammation progressing to ischemic necrosis of the renal medulla, a life-threatening disease which has been described under the terms necrotizing papillitis, papillary necrosis and necrotizing pyelonephritis but here designated renal medullary ...
D P, LAULER, G E, SCHREINER, A, DAVID
openaire   +5 more sources

Multiple endocrine neoplasia type 2B: A genotype-phenotype diagnostic and therapeutic approach

open access: yesIatreia, 2023
Multiple endocrine neoplasia type 2B (MEN 2B) is a rare genetic syndrome with an estimated prevalence of 0.9 to 1.6 per million individuals and an annual incidence of 1.4 to 2.6 per million live births.
Valentina Agredo Delgado   +2 more
doaj   +1 more source

Mixed medullary—papillary thyroid carcinoma with mixed lymph node metastases: A case report

open access: yesClinical Case Reports, 2021
Mixed medullary‐follicular‐derived carcinoma is a very rare event. It is extremely important to make the correct diagnosis, due to prognostic and treatment implications. A genetic study of these patients is advisable to exclude the presence of MEN 2.
Vanessa Guerreiro   +8 more
doaj   +1 more source

Histopathological and immunohistochemical features of thyroid carcinoma [PDF]

open access: yesArchive of Oncology, 2003
Thyroid-specific malignant tumors are derived from follicle cells (papillary and follicular carcinoma), and from parafollicular, calcitonin-producing C-cells (medullary carcinoma). The main criterion for diagnosis of papillary carcinoma is the occurrence
Tatić Svetislav B.
doaj   +1 more source

Thyroid: Medullary carcinoma [PDF]

open access: yesAtlas of Genetics and Cytogenetics in Oncology and Haematology, 2013
Medullary thyroid cancers (MTC) are rare neuroendocrine tumors arising from the parafollicular C-cells of the thyroid. In this review, we provide a general overview of the classification, pathology, and clinical management of MTC. In the latter half, we survey the underlying genetic framework of MTC and its potential implications within a diagnostic ...
Somnay, Y, Schneider, D, Mazeh, H
openaire   +3 more sources

Radionuclide therapy in the treatment of thyroid malignancy [PDF]

open access: yesArchive of Oncology, 2003
In this paper we presented the principles of performance of radionuclide therapy, its adverse effect, together with mentioned complications obligation to use it only according to directions and the success of the therapy, which is seen through the length
Malešević Milica Đ.
doaj   +1 more source

Home - About - Disclaimer - Privacy